Trial NCT02999633

View at ClinicalTrials.gov 
Org. Study IDs: ACT14596
Secondary IDs: 2016-002739-14 U1111-1179-5294

Last trial update was posted on 2022-03-21

MeSH Interventions

Acetaminophen BB 1101 Dexamethasone Dexamethasone acetate Diphenhydramine Promethazine Ranitidine Ranitidine bismuth citrate

MeSH Conditions

Leukemia Leukemia, Lymphoid Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia

Stopping Reasons

Due to an unsatisfactory benefit/risk ratio, as specified in & 14.8.1 of the protocol, Sanofi decided to stop enrollment and terminate ACT14596 prematurely

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID